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Abstract
Background: Children with Sickle Cell Disease (SCD) may show growth failure in comparison to healthy peers.
Many factors as hematological status, endocrine and/or metabolic dysfunction, and nutritional status, may play an
important role in growth failure. The aim of this study was to assess whether impaired growth and nutritional
intake can affect SCD severity during childhood.
Methods: We conducted an observational study on children with SCD referring to our clinic for routine follow-up
visits in a 6-month period. We collected information on weight, height and body mass index (BMI) and calculated
their respective standardized scores (z). The nutritional intake was assessed through the last 24-h recall intake of
total calories, macro- (proteins, lipids, carbohydrates) and micronutrients (calcium, iron, phosphorus, vitamins B1, PP,
A, C, B2). Disease severity was assessed through total hemoglobin (Hb) and fetal hemoglobin (HbF), and lactic
dehydrogenase (LDH) levels, and through the total number and days of hospitalizations, as well as the lifetime
episodes of acute chest syndrome (ACS).
Results: Twenty nine children (14 males, 15 females) with SCD were enrolled; their mean age was 9.95 years (SD
3.50, min 3.72, max 17.18). Z-weight and z-BMI were significantly directly related to total Hb. Food intake resulted
significantly unbalanced in terms of total calorie intake, macro- and micronutrients, especially calcium, iron, vitamin
B1 and C. Low intake of calcium and vitamin B1 were significantly inversely correlated with number and days of
hospitalizations per year. Protein, lipid, phosphorus, and vitamin PP intakes resulted adequate but were inversely
correlated with number and days of hospitalizations. Carbohydrate, lipid, iron, phosphorus, vitamins B1 and B2
intakes were significantly inversely correlated to HbF levels.
Conclusions: This study showed that, in our population, inadequate nutritional intake, weight and BMI have a
significant impact on SCD severity indices.
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Background
SCD is a life-threatening genetic disorder characterized
by chronic hemolytic anemia, vascular injury and organ
dysfunction. Over the last few decades there has been a
significant improvement in the management of patients
with SCD. However, SCD may affect physical growth
during childhood and early adolescence, and children
with this condition are often leaner and shorter than
their healthy peers [1]. The prevalence of low weight in
American children with SCD is 41 % with moderate and
25 % with severe under-nutrition, with a prevalence of
wasting of 11 % [2, 3]. Growth failure in SCD seems to
depend on multiple factors: hematologic and cardiovas-
cular status, endocrine and metabolic functions, and
nutritional status [4]. Patients with SCD have a series of
micronutrient deficiencies: vitamins A, B2, B6, B12, C, D
and E, folic acid, iron, calcium, magnesium and zinc [5].
It has been suggested that a better nutrition could im-
prove body composition, especially lean mass, and have
a positive impact on SCD morbidity and mortality [6].
Folic acid is widely administered to children with SCD,
although its optimal daily requirement has not been
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established. Other nutrients such as zinc, glutamine, L-
arginine and antioxidants could provide important
therapeutic benefit in children with SCD [5].
Although growth failure and under-nutrition are com-
mon, the underlying mechanisms have not been well
studied and the precise roles of intrinsic and extrinsic
factors are unclear. Inadequate food intake or increased
demands associated with higher energy expenditure and
requirements could be both responsible [6].
The aim of this study was to assess whether impaired
growth and nutritional intake may affect SCD severity in
children.
Methods
We conducted an observational study involving children
with SCD referring to our clinic during a 6-month
period for their routine follow-up visits. Inclusion cri-
teria were age between 6 months and 18 years and SCD
diagnosis. Patients with comorbidities, lost to follow-up
or transferred to other centers were excluded. All pa-
tients underwent a complete clinical history and physical
examination including anthropometric measurements
that were performed by fully-trained examiners accord-
ing to the Anthropometric Standardization Reference
Manual [7]. Height was measured to the nearest 0.1-cm
with a calibrated wall mounted stadiometer (Harpenden,
Crymych; UK) and weight was measured to the nearest
0.1-kg with a calibrated scale. BMI was calculated by
dividing weight in kg by height squared (m2). Z-height,
z-weight and z-BMI were calculated using the British
1990 Growth Reference Data, by using the site http://
www.paediatrics.co.uk/nicu/growth-charts.
As indices of severity we considered average of total Hb,
HbF and LDH over the last 6 months, as well as the aver-
age number of hospitalizations and days of hospitalization
per year, and the total number of lifetime ACS episodes.
Nutritional intake was assessed with a last 24-h food
recall and through the average weekly consumption of
major food categories. The major food categories exam-
ined were: meats, fish, eggs, cheese, milk, fruits, vegeta-
bles, grains, legumes, and sugary beverages. The amount
of food intake was assessed using a photographic atlas of
food portions corresponding to precise quantities (milli-
liters, grams). To avoid biases due to an unusual type of
diet in the 24-h recall diary, we compared it to the
weekly consumption of major food categories.
The estimated total calories, macronutrients (proteins,
carbohydrates, lipids) and micronutrients (calcium, iron,
phosphorus, vitamins B1, B2, PP, A and C) daily intakes
were calculated for each child using the software “La
dieta del Sole” (M. Riva, M. Paolazzi, G. Orlandi, Coop)
used by the Italian National Research Institute for Food
and Nutrition. For each child we also calculated,
depending on age, gender, height, weight, and physical
activity, the daily requirement of calories, macro- and
micronutrients according to LARN (Level Assumption
Recommended Nutrients-SINU, 3rd edition).
Finally we compared calorie and macro- and micronu-
trients daily requirements with the actual intake: the
results were showed as percentage.
All results are reported as the mean (SD, min, max).
The variables examined in the study were compared
with Student’s t-test, analysis of variance and multiple
regressions. All continuous variables that didn’t show a
normal Gaussian distribution were transformed into nat-
ural logarithm. A p-values less than or equal to 0.05 was
considered statistically significant. All analyses were per-
formed with SPSS® 13.0 for Windows.
The study received the approval of the local Ethics
Committee of the University Hospital of Modena (prot.
n. 68/13, date June 12, 2015).
Results
Fourteen males (48.3 %) and 15 females (51.7 %) were
enrolled in the study. Their mean age was 9.95 years
(SD 3, min 3.72, max 17.18). Mean anthropometric mea-
sures were: weight 32.93 Kg (SD 13.76, min 15, max 64),
z-weight -0.15 (SD 1.30, min -3.16, max 2.26); height
135.55 cm (SD 17.43, min 100, max 173), z-height -0.04
(SD 1.17, min -2.41, max 1.61); BMI 17.11 (SD 3.05, min
12.8, max 23.5), z-BMI -0.14 (SD 1.1, min -2.42, max
2.31). Clinical indices of disease severity were: mean
number of hospital admissions per year 1.07 (SD 1.03,
min 0, max 4), mean number of days of hospital admis-
sion per year 7.15 (SD 7.65, min 0, max 24), mean num-
ber of lifetime episodes of ACS 1.24 (SD 2.08, min 0,
max 8). Mean hematological indices of disease severity
were: total Hb 9.59 gr/dl (SD 1.71, min 5.9, max 13.7),
HbF 8.13 gr/dl (SD 9.12, min 0.6, max 45.3), LDH
924.32 U/L (SD 368.92, min 468, max 1768).
Using analysis of variance, z-weight (α = 9.672, β = 0.545,
r2 = 0.171, p = 0.026) and z-BMI (α = 9.671, β = 0.590, r2 =
0.152, p = 0.037) resulted significantly directly related to Hb
levels. All other anthropometric measures didn’t show any
significant correlation to disease severity indices.
Desired daily amount and actual daily intake of total
calories, macro- and micronutrients were compared
using Student’s t-test and resulted all significantly differ-
ent. Protein, vitamin PP and A intakes were significantly
over daily requirement; total caloric intake, carbohy-
drate, lipid, as well as all minerals (except phosphorus)
and remaining vitamin intakes were significantly below
daily requirement (Table 1).
The correlation of total calorie, macro- and micronu-
trient intakes, expressed as percentage of their respective
daily requirements, with clinical and hematological indices
of SCD severity were analyzed with analysis of variance.
Using multiple regression analyses, sex and age didn’t
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show any influence on all the dependent variables of dis-
ease severity, so they were excluded from the statistical
models. The number of hospital admissions per year was
significantly inversely correlated to lipid, calcium, phos-
phorus and vitamin PP intakes. The days of hospital
admission per year were significantly inversely correlated
to protein, lipid, phosphorus, vitamins B1 and PP intakes.
Levels of HbF were significantly inversely correlated to the
intake of carbohydrates, lipids, iron, phosphorus, vitamins
B1 and B2. All information of these correlations are
reported in Table 2. Lifetime episodes of ACS, total Hb
and LDH levels were not correlated to calorie, macro- and
micronutrient intakes. Total calorie intake was not signifi-
cantly correlated to any of the severity indices, as well as
the intakes of vitamins A and C.
The comparison of the last 24-h recall with weekly
intake information didn’t show any statistical difference:
therefore, only the information obtained from the last
24-h recall intake were reported.
Discussion
Our study showed that body weight and BMI are signifi-
cantly directly related to total Hb mean values, and thus
to the severity of SCD. Several macro- and micronu-
trient intakes were inadequate, many of them showing a
significant impact on number and days of hospital
admissions. HbF, protective on SCD, on the other hand,
was negatively correlated to several nutrients. To our
knowledge, this is the first study that extensively evalu-
ated the nutritional intake of macro- and micronutrients
and its effect on SCD severity.
Standardized weight and BMI contributed, in our popu-
lation, to the 17 and 15 % respectively of the total variance
of total Hb levels. These findings are in line with others
studies that reported a relationship between growth fail-
ure, and/or inadequate nutritional intake, and disease
severity in SCD patients, suggesting that a targeted nutri-
tional intervention could reduce the clinical severity of
SCD [8]. Growth deficiency and undernourishment have
Table 1 Comparison between daily nutrient requirement and estimated patients’ intake of calories, macronutrients, minerals and
vitamins
Daily Requirement mean ± SD Patients’ Intake mean ± SD p % Daily intake/Daily
requirement mean ± SD
(min-max) (min-max) (min-max)
MACRO NUTRIENTS Calories (Kcal) 1798 ± 301 1514 ± 325 <0.001 85.62 ± 20.43
(1047–2403) 956–2109 51.68–141.24
Carbs (g) 251.41 ± 39.33 220.79 ± 52.72 <0.001 88.97 ± 21.28
(152–332) 117–337 43.33–134.87
Protein (g) 42.38 ± 13.84 52.28 ± 14.71 <0.001 133.10 ± 49.42
18–74 25–80 66.67–231.82
Lipids (g) 69.21 ± 11.69 55.10 ± 11.44 <0.001 96.21 ± 29.02
41–93 32–82 14.44–157.89
MINERALS Ca2+ (mg) 869.59 ± 221.7 462.2 ± 240.9 <0.001 56.43 ± 34.41
508–1293 119–1321 16.79–146.13
Fe (mg) 10.67 ± 3.96 5.85 ± 2.20 <0.001 59.15 ± 24.99
6–20 2.17–11.04 25.09–106.67
P (mg) 869.59 ± 221.7 831.5 ± 246.4 <0.001 100.1 ± 35.14
508–1293 361–1611 51.85–175.19
VITAMINS B1 (mg) 0.81 ± 0.17 0.44 ± 0.15 <0.001 55.4 ± 17.72
0.44–1.18 0.17–0.81 23.94–96.00
PP (mg) 12.17 ± 2.57 23.73 ± 7.15 <0.001 198.6 ± 57.74
7–17 13–38 117.60–330.80
A (mcg) 470.41 ± 96.89 521.19 ± 296.7 <0.001 120.5 ± 88.28
253–646 139–1216 29.52–425.32
C (mg) 43.55 ± 8.48 32.05 ± 29.94 <0.001 72.9 ± 65.39
28–64 4–113 8.45–267.64
B2 (mg) 0.97 ± 0.23 0.91 ± 0.41 <0.001 96.7 ± 52.42
0.50–1.51 0.31–2.22 38.75–250.00
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already been described in patients with SCD, but the
underlying mechanism and the precise role of potential
intrinsic and extrinsic factors related to inadequate food
intake or increased demands, associated with higher
energy costs, are still unclear [6]. Inadequate nutritional
intake, micronutrient deficiency, endocrine dysfunction
and hypermetabolism have been suggested as main factors
that may contribute to growth failure in children with
SCD [9]. A series of study, indicated that children with
SCD have a basal metabolic rate and resting energy
expenditure higher than their healthy peers; this increases
their metabolic, energy and protein demands. As a result,
inadequate food intake found in our patients could be
even more serious compared to those considered for sub-
jects with same age, sex and anthropometric measures,
but not suffering from a chronic disease [5, 10–13].
Weight and BMI didn’t show, however, any influence on
other clinical and hematologic variables examined in our
study, besides total Hb. This could be explained by the
relatively small number of patients involved in this study
and the even smaller number of children with very low
weight and BMI, leading to low statistical power.
The analysis of the last 24-h recall food intake of our pa-
tients, with the software used by the Italian National
Research Institute for Food and Nutrition, showed that
total calorie, some macro- and micronutrient intakes
were significantly inadequate when compared to daily
requirements. The most deficient intakes involved cal-
cium, iron, vitamins B1 and C. Total calorie, carbohydrate,
lipid, and vitamin B2 intakes were only moderately below
daily requirements, while protein and vitamins PP and A
intakes in our population were high. This is because the
diet of our children was mainly based on meat, canned
tuna, rice and carrots. Total calorie intake didn’t show, in
our population, any correlation with clinical and
hematologic variables. Regarding macronutrients, proteins
showed a significant negative correlation to the number of
days of admission per year and carbohydrates to HbF.
Lipid intake was significantly inversely related to the num-
ber and days of hospitalization, and to HbF. Heyman et al.
claimed that nutritional supplementation may reduce clin-
ical illness, and supplements administered by nasogastric
tube to children with SCD and growth deficit (weight and
height below the 5th percentile) have led to a rapid and
substantial increase in their growth and to a reduction of
painful crises and infectious episodes [8]. Wang et al.,
found that therapies such as transfusion therapy,
splenectomy and treatment with hydroxyurea reduce
disease severity or its complications, inducing an
improvement in nutritional status and growth in patients
with SCD [14]. Also VanderJagt et al. argued that paying
more attention to food intake could improve body com-
position, especially regarding lean mass, having a positive
impact on morbidity and mortality [5]. On the other hand,
Table 2 Effects of macro- and micronutrients on indices of disease severity
N° hospital admission/yr N° days of hospital admission/yr Mean HbF
Proteins ns α = 2.831 β =−0.009 r2 = 0.179 ns
p = 0.022
Carbohydrates ns ns α = 3.438 β =−0.019 r2 = 0.208
p = 0.033
Lipids α = 2.425 β =−0.014 r2 = 0.157 α = 2.931 β =−0.014 r2 = 0.138 α = 2.998 β =−0.013 r2 = 0.241
p = 0.033 p = 0.047 p = 0.020
Calcium α = 4.026 β =−0.762 r2 = 0.168 ns ns
p = 0.027
Iron ns ns α = 2.600 β =−0.014 r2 = 0.185
p = 0.045
Phosphorus α = 2.199 β =−0.011 r2 = 0.147 α = 3.065 β =−0.015 r2 = 0.227 α = 2.954 β =−0.012 r2 = 0.232
p = 0.040 p = 0.009 p = 0.023
Vitamin B1 ns α = 2.911 β =−0.024 r2 = 0.151 α = 3.023 β =−0.023 r2 = 0.437
p = 0.037 p = 0.042
Vitamin PP α = 2.552 β =−0.007 r2 = 0.174 α = 3.479 β =−0.009 r2 = 0.255 ns
p = 0.024 p = 0.005
Vitamin B2 ns ns α = 2.459 β =−0.007 r2 = 0.208
p = 0.033
Calories, vitamins A and C, as well as total Hb levels and lifetime episodes of ACS didn’t show any statistically significant correlation and are not reported in the table
ns not statistically significant
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Peters et al. found that ketones generated from fasting
can reactivate production of HbF; in particular B-
hydroxybutyrate generated from fasting are associated
with increased levels of HbF. In this way, uncontrolled
lipolysis could produce B-hydroxybutyrate in such
quantities as to induce a clinically significant increase
in HbF levels [15]. It could be worthwhile to study the
possibility of increasing the levels of HbF in patients
with SCD through a particular type of diet, resulting in
a potential improvement of their condition.
In our patients, calcium and phosphorus intakes were sig-
nificantly inversely related to the number of hospitalizations
the first, and to both number and days of hospitalizations
the latter. Iron and phosphorus intakes showed a significant
negative correlation to HbF levels, thereby appearing to be
protective in SCD. Kawchak et al., evaluating the daily
intake over the last 24 h in American children with SCD,
showed a sub-optimal intake of many nutrients in all ages,
including a low intake of vitamins D and E, folic acid, cal-
cium, phosphorus, magnesium and zinc, tending to a
poorer diet with increasing age, especially during adoles-
cence [16]. Iron deficiency is also very common in subjects
with SCD [17], especially among children living in develop-
ing countries where iron deficiency anemia is widespread
[18]. This finding is in agreement with our study, in which
almost all patients didn’t take the recommended daily
amount of iron, with very consistent deficit in some cases.
Iron deficiency in patients with SCD may be beneficial be-
cause it could reduce red blood cell sickling by decreasing
the mean corpuscular hemoglobin concentration with con-
sequent reduction of hemolysis [19, 20] and painful crises
[21]. It has also been suggested that iron supplementation
might trigger painful crises [22]. Evidences of clinical bene-
fit of iron deficiency are still minimal and limited because
of the difficulties in assessing disease severity [23]. At the
same time iron deficiency is, however, associated with a
reduction of physical and intellectual growth [24]. Children
with iron deficiency are therefore at risk of both growth
and neurocognitive delay [5].
Vitamin B1 intake significantly inversely correlated to
HbF levels, contributing to the 44 % of its total variance,
as vitamin B2. Vitamin B1 and PP intakes were signifi-
cantly negatively correlated to the number of days of
hospitalization. Vitamins A and C didn’t have any
impact on clinical severity indices in our study. Other
studies have shown the correlation between vitamin A
deficiency and SCD clinical severity. Schall et al. showed
that the serum level of vitamin A in American children
with SCD was normal in 66 % of cases and inadequate
in 17 % of cases and the rate of hospital admissions was
higher in children with vitamin A deficiency [25]. In our
study, we didn’t find any significant correlation between
the intake of vitamin A and disease severity. This can be
explained by the evidence that our patients took, on
average, higher amounts of vitamin A than the recom-
mended daily requirement. An insufficient intake of vita-
min C in SCD subjects has already been reported in the
literature [26].
Current SCD disease treatment guidelines only
underline the importance of specific micronutrients
(folic acid, zinc, iron) for their involvement in inflam-
matory status and immunity, but make no reference to
the importance of maintaining an adequate complete
nutritional intake [1, 27–29].
In our study, we clearly showed that body weight and
BMI can affect SCD severity, as well as inadequate spe-
cific nutrient intakes. An unexpected result was the
beneficial effect that low intakes of several macro- and
micronutrients can have on HbF level, known to be pro-
tective against SCD complications. Weaknesses of this
study were the small number of enrolled subjects and
using data derived from simple interviews with patients
regarding their nutritional habits, therefore potentially
not as reliable as measurement of serum levels.
Conclusions
In this study we showed that low body weight and BMI
can negatively affect total Hb levels, one of the most
important parameters to define SCD severity. This des-
pite the small number of subjects enrolled in the study.
Although specific macro- and micronutrient low intakes
can have a significant negative impact on disease severity
assessed through number and days of hospital admis-
sions, they also seem to potentially protect patients
through an increase in HbF levels.
This study also suggests the importance of regular
nutritional and anthropometric assessments in SCD
children not indicated in current SCD treatment
guidelines.
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